MARKET

QDEL

QDEL

Quidel
NASDAQ

Real-time Quotes | Nasdaq Last Sale

146.94
-6.53
-4.25%
After Hours: 146.40 -0.54 -0.37% 19:56 09/24 EDT
OPEN
153.80
PREV CLOSE
153.47
HIGH
153.93
LOW
146.94
VOLUME
406.03K
TURNOVER
--
52 WEEK HIGH
288.70
52 WEEK LOW
103.31
MARKET CAP
6.12B
P/E (TTM)
7.12
1D
5D
1M
3M
1Y
5Y
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests.
Benzinga · 14h ago
COVID-19 test maker Cue Health prices 12.5M-share IPO at $16
Cue Health (NASDAQ:HLTH) has priced its IPO of 12.5M shares of common stock at $16.00/share, for gross proceeds of $200M at a target valuation of around $2.4B. Nasdaq trading commences on September
Seekingalpha · 1d ago
U.S. to buy $554 million worth of rapid COVID-19 antigen tests from Abbott
The U.S. government is set to spend $554.4 million to buy rapid COVID-19 tests from Abbott Laboratories (NYSE:ABT) in a bid to supply nursing homes and other high-risk populations, Reuters reported citing
Seekingalpha · 2d ago
Brown Capital Management Small Company Fund Buys 10x Genomics Inc, Smartsheet Inc, Alarm. ...
GuruFocus News · 6d ago
Quidel bags $710.6M Defense Logistics contract for antigen test
Quidel (NASDAQ:QDEL) has been awarded a maximum ~$710.6M ID/IQ contract for over-the-counter antigen test kits. This is a one-year contract with no option periods. Location of performance is all 50
Seekingalpha · 09/17 21:36
OraSure reaches a seven-month high as Raymond James points to federal contract
Recording the biggest intraday gain since October, the shares of OraSure Technologies (OSUR +12.3%) have approached the highest level since February after Raymond James cited a federal contract won by
Seekingalpha · 09/17 17:54
Fuller & Thaler Behavioral Small-mid Core Equity Buys Pool Corp, Science Applications ...
GuruFocus News · 09/16 19:38
3 Diagnostics Stocks in Focus on Biden's Delta Variant Mandate
Zacks.com · 09/14 13:58
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of QDEL. Analyze the recent business situations of Quidel through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average QDEL stock price target is 133.00 with a high estimate of 219.00 and a low estimate of 70.00.
EPS
Institutional Holdings
Institutions: 448
Institutional Holdings: 42.53M
% Owned: 102.15%
Shares Outstanding: 41.63M
TypeInstitutionsShares
Increased
115
3.29M
New
54
2.00M
Decreased
109
2.95M
Sold Out
71
498.71K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.19%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Non-Executive Chairman/Independent Director
Kenneth Buechler
Chief Executive Officer/President/Director
Douglas Bryant
Chief Financial Officer
Randall Steward
Chief Operating Officer
Robert Bujarski
Senior Vice President/General Counsel
Michelle Hodges
Senior Vice President
William Ferenczy
Senior Vice President
Karen Gibson
Senior Vice President
Werner Kroll
Senior Vice President
Tamara Ranalli
Senior Vice President
Edward Russell
Independent Director
Edward Michael
Independent Director
Kathy Ordonez
Independent Director
Mary Polan
Independent Director
Ann Rhoads
Independent Director
Charles Slacik
Independent Director
Matthew Strobeck
Independent Director
Kenneth Widder
Independent Director
Joseph Wilkins
No Data
About QDEL
Quidel Corp. is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: rapid immunoassays, cardiac immunoassay, specialized diagnostic solutions and molecular diagnostic solutions. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of many diseases and medical conditions, including infectious diseases, cardiovascular diseases and conditions, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Amplivue, Lyra and Thyretain.

Webull offers kinds of Quidel Corporation stock information, including NASDAQ:QDEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QDEL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QDEL stock methods without spending real money on the virtual paper trading platform.